| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Prestige Consumer Healthcare Inc. (PBH) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. PBH is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 58.3K | $2.71M | - | |
| Dir | 51.6K | $2.39M | - | |
| VP | 41.0K | $1.90M | - | |
| Dir | 30.1K | $1.40M | - | |
| Dir | 16.5K | $767.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2017 | Boyko Jean A | SVP, Science And Technology | Sale+OE | 12,876 | $52.12 | $671,097.12 | -48.5% | |
| Jun 8, 2016 | Byom John E | Director | Sell | 1,249 | $53.35 | $66,634.15 | -4.5% | |
| Jun 8, 2016 | Parkinson John | Senior Vp- International | Sale+OE | 25,143 | $53.57 | $1,346,910.51 | -28.1% | |
| May 31, 2016 | Boyko Jean A | SVP, Science And Technology | Sell | 3,500 | $53.78 | $188,230.00 | -21.5% | |
| May 27, 2016 | Cowley Samuel C54 | General Counsel And VP | Sale+OE | 32,599 | $54.67 | $1,782,187.33 | -25.2% | |
| May 27, 2016 | Migaki Paul | See Remarks | Sale+OE | 26,877 | $54.51 | $1,465,065.27 | -13.8% | |
| Jun 15, 2015 | Parkinson John | Senior Vp- International | Sell | 16,695 | $44.99 | $751,108.05 | -21.1% | |
| Jun 10, 2015 | Parkinson John | Senior Vp- International | Sale+OE | 9,104 | $44.29 | $403,216.16 | -10.3% | |
| Jun 1, 2015 | Mannelly Matthew | President And CEO | Sale+OE | 19,670 | $44.16 | $868,713.60 | -26.2% | |
| May 21, 2015 | Boyko Jean A | SVP, Science And Technology | Sell | 12,583 | $43.12 | $542,578.96 | -44.7% |